The biggest European MedTech developments this week centre on the EU’s proposed overhaul of MDR/IVDR, a broader Commission health package to boost innovation and resilience, and continued capital formation for MedTech and digital health scale‑ups.  Together these moves signal a more innovation‑friendly regulatory path and fresh growth funding for European MedTech heading into 2026.​